Where is Alcon Corporate office Headquarters

Alcon Headquarters Address and Contact

Alcon
  • Address:  6201 South Freeway, Fort Worth, TX 76134-2099, United States
  • Phone Number: 817-293-0450
  • Fax Number: 817-568-7128
  • Email: N/A
  • heart
    Number of Employees: 19,000 
  • Established: 1945
  • Founder: N/A
  • Key People: Mr. Jeffrey George (President)

Alcon Headquarters Location & Directions

Alcon Headquarters Executive Team

Name

Title

Mr. Ed McGough

Senior Vice President of Global Manufacturing and Technical Operations

Ms. Elaine E. Whitbeck Esq.

Senior Vice President, Chief Legal Officer, General Counsel, and Corporate Secretary

Mr. Merrick McCracken

Senior Vice President of Human Resources

Mr. William K. Barton

Senior Vice President of International Markets

About Alcon, History and Headquarters Information

History

Alcon was founded in the year 1945. The company has been operational for almost 74 years now. The company had started its operations as a small type of pharmacy. The founders of the company were Robert Alexander and William Conner. Both of the company founders were pharmacists. The company mostly focused on sterile ophthalmic products. In the year 1977, the company was taken over by Nestle. After the takeover, the company expanded with its new manufacturing plants in Europe and South America and therefore increased its research segment as well. In the year 1979, the company had taken over Texas Pharmacal Company, which was later renamed to Dermatological Products of Texas. Then in the year 1984, the company had found the Technical Excellence Award, which was awarded for R&D excellence and was given to more than 100 recipients. The company also started to make products in the surgical area as well. It has its operations in over 75 countries and sells its products to over 180 countries worldwide.

In the year 2002, the company had conducted its first IPO or Initial Public Offering. In the year 2008, Novartis had purchased almost 25 per cent stake of Nestle in Alcon. By the year 2010, Novartis had captured another 52 per cent share in the company as well for about $28.1 billion, making the overall share per cent rise to almost 77 per cent. In the year 2010, Alcon had acquired companies like Zyclorin and Durezol from Sirion Therapeutics. The same year, the independent directors of the company had set up a $50 million litigation trust as well. This was to ensure that the minority shareholders will get the best deal from bidder Novartis AG. By the year 2019, the company had completed a 100 per cent spin-off from Novartis. The headquarters of the company is based in 6201 South Freeway. The name o the place in Fort Worth, while the name of the state is Texas, USA. The pin code of the area is 76134-2099.

About

Alcon is an American company that focuses on the designing and development of various types of innovative medicines along with devices as well, in order to serve its customers in the eye care industry. The current CEO of the company is David Endicott. As of the year 2017, the total revenue generated by the company is more than $7 billion. Also, the number of employees working at the company is more than 20,000, as of the year 2017.

Services

The primary services provided by the company include allowing customers to purchase various kinds of eyewear products developed, designed and sold by the company itself. The company is also responsible for developing surgical products, over the counter products as well as contact lenses too as well.

Alcon Headquarters Photos

Rate This
  • REX DOHERTY says:

    REX DOHERTY
    2862 BOA VISTA DRIVE, COSTA MESA, CALIFORNIA 92626
    email: rex.doherty@yahoo.com cell: 714 862 5486
    JANUARY 6, 2022
    JEFFREY GEORGE of ALCON,
    GENTLEMEN—I HAVE A NEW FORMULA THAT STOPS AMD !!!!
    I am contacting you because of you great success in bringing new solutions to old problems with superb marketing, sales and MY GRANTING INFORMATION TO YOU THAT CAN LEAD TO THE PATENTING OF THE ONLY MAJOR AMD DRUG —THAT ACTUALLY STOPS AMD!!!!!
    I was diagnosed with DRUSEN in 2002 which gradually developed into dry AMD. Even though I began AREDS/PRESSER VISION and LETUIN in 2002, slow AMD progression took away my left eve central vision 8 years ago—peripheral vision is unaffected. After which I ramped up my research and self experimentation to find a pharmaceutical combination that would at least save my right eye central vision. halted plaque progression for 5 years— can still drive and read very well.
    I have discovered a formulation of OTC and Prescriptive formulations (should be combined into 1 or 2 pills) which STOPPED my AMD progression and STOPPED all additional plaque growth 5 years ago. I am quite happy about this development and even more excited, just recently, I started seeing partial central vision returning in my left eye. Perhaps an increase of 2 certain compounds will further promote plaque regression—A REAL HOPE!
    I believe that ALCON should enter the worldwide market of about 300 million, 25 million in the USA, AMD patients who have NO hope for a cure with almost NO useful treatments—certainly none that slows or stops disease progression which my formulation has done!
    Please let me know if you would like to discuss my discovery further. Thanks.

    REX DOHERTY

     
  • REX DOHERTY says:

    REX DOHERTY
    2862 BOA VISTA DRIVE, COSTA MESA, CALIFORNIA 92626
    email: rex.doherty@yahoo.com cell: 714 862 5486
    JANUARY 4, 2022
    ALCON USA HEADQUARTERS

    MR GEORGE,

    GENTLEMEN,
    I HAVE A NEW FORMULA THAT STOPS AMD!
    I am contacting you because of you great success in bringing new solutions to very old problems with superb marketing and sales. I am not a chemist, my career has been an inventing entrepreneur for diagnostic and surgical medical devices.
    I was diagnosed with DRUSENS in 2002 which gradually developed into dry AMD. (I am now a healthy 83 years old.) Even though I began AREDS and LEUTIN in 2002, slow disease progression took away my left eve central vision about 8 years ago—peripheral vision is unaffected. After which I ramped up my research and self experimentation to find a pharmaceutical combination that would at least save my right eye central vision. My ophthalmologist has been unenthused about all available treatment trials for me—especially since I have halted plaque progression for 5 years— can still drive and read very well.
    I have discovered a formulation of OTC and Prescriptive formulations which slowed my disease’s progress and then stopped all additional plaque growth 5 years ago. I am quite happy about this development and even more excited that, just recently, I started getting flashes of returning central vision in my left eye. Perhaps an increase of 2 certain compounds will promote plaque regression—A big hope!
    I believe that ALCON just might want to enter the worldwide market of about 300 million, 25 million in the USA, AMD patients who have no hope for a cure with almost NO useful treatments—certainly none that slows or stops disease progression which my formulation has done.
    Please let me know if you would like to discuss my discovery further. Thanks.
    REX DOHERTY

     
  • >